Parkinson's Disease and pathological gambling: Results from a functional MRI study

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2449-2453

  Frosini, Daniela ^a   Pesaresi, Ilaria ^a   Cosottini, Mirco ^a   Belmonte, Gina ^a   Rossi, Carlo ^a   Dell'Osso, Liliana ^a   Murri, Luigi ^a   Bonuccelli, Ubaldo ^a   Ceravolo, Roberto ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

FMRI; Parkinson's disease; Pathological gambling

Indexed keywords

ADULT; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROENCEPHALOGRAM; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; OXYGEN BLOOD LEVEL; PARIETAL LOBE; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; STIMULUS RESPONSE;

AGED; BRAIN; BRAIN MAPPING; CUES; FEMALE; GAMBLING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PARKINSON DISEASE; PHOTIC STIMULATION;

EID: 77958574093     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23369     Document Type: Article

References (16)

1. American Psychiatric Association. Diagnostic and statistical manual of mental, fourth edition. Washington, DC: American Psychiatric Press; 1994.
2. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216.
3. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007; 22: 1757-1763.
4. Antonini A, Tolosa E, Mizuno Y, Yamamoto M, Poewe WH. A reassessment of risks and benefits of dopamine agonists in Parkinson's disease. Lancet Neurol 2009; 8: 929-937.
5. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008; 65: 1604-1611.
6. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009; 132: 1376-1385.
7. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction 2006; 101( Suppl 1): 142-151.
8. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
9. Grosset K, Needleman F, Macphee G, Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004; 19: 1370-1374.
10. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain: 3-D proportional system: an approach to cerebral imaging. New York: Thieme Medical Publishers; 1988.
11. Friston KJ, Holmes AP, Poline JB, et al. Analysis of fMRI time-series revisited. Neuroimage 1995; 2: 45-53.
12. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005; 58: 787-795
13. Park MS, Sohn JH, Suk JA, Kim SH, Sohn S, Sparacio R. Brain substrates of craving to alcohol cues in subjects with alcohol use disorder. Alcohol Alcohol 2007; 42: 417-422.
14. Wexler BE, Gottschalk CH, Fulbright RK, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001; 158: 86-95
15. Ko CH, Liu GC, Hsiao S, et al. Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 2009; 43: 739-747.
16. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Büchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005; 8: 147-148.